Cargando…

Differences in the Distribution of Ceramides and Sphingosine among Lipoprotein and Lipoprotein-Depleted Fractions in Patients with Type 2 Diabetes Mellitus

Aim: In addition to the quantity and quality, the carriers, such as lipoproteins and albumin, can affect the physiological properties and clinical significance of lipids. This study aimed to elucidate the modulation of the levels of ceramides and sphingosine, which are considered as proatherosclerot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurano, Makoto, Tsukamoto, Kazuhisa, Sakai, Eri, Yatomi, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881536/ https://www.ncbi.nlm.nih.gov/pubmed/35082227 http://dx.doi.org/10.5551/jat.63249

Ejemplares similares

Sphingosine 1-Phosphate and Atherosclerosis
por: Kurano, Makoto, et al.
Publicado: (2018)

Modulation of sphingosine-1-phosphate and apolipoprotein M levels in the plasma, liver and kidneys in streptozotocin-induced diabetic mice
por: Nojiri, Takahiro, et al.
Publicado: (2014)

Suppression of sphingosine 1-phosphate lyase retards the liver regeneration in mice after partial hepatectomy
por: Kageyama, Yuko, et al.
Publicado: (2020)

Understanding modulations of lipid mediators in cancer using a murine model of carcinomatous peritonitis
por: Kurano, Makoto, et al.
Publicado: (2022)

Involvement of Band3 in the efflux of sphingosine 1-phosphate from erythrocytes
por: Kurano, Makoto, et al.
Publicado: (2017)

Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate
por: Mishima, Yuko, et al.
Publicado: (2018)

Sphingosine 1‐phosphate lyase facilitates cancer progression through converting sphingolipids to glycerophospholipids
por: Uranbileg, Baasanjav, et al.
Publicado: (2022)

Simultaneous analyses of urinary eicosanoids and related mediators identified tetranor-prostaglandin E metabolite as a novel biomarker of diabetic nephropathy
por: Morita, Yoshifumi, et al.
Publicado: (2021)

Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration
por: Ono, Yoshikazu, et al.
Publicado: (2013)

Glycation of HDL Polymerizes Apolipoprotein M and Attenuates Its Capacity to Bind to Sphingosine 1-Phosphate
por: Kobayashi, Tamaki, et al.
Publicado: (2021)

Platelet-derived sphingosine 1-phosphate induces migration of Jurkat T cells
por: Iino, Junko, et al.
Publicado: (2014)

Analysis of urinary sphingolipids using liquid chromatography‐tandem mass spectrometry in diabetic nephropathy
por: Morita, Yoshifumi, et al.
Publicado: (2019)

Light Stress-Induced Increase of Sphingosine 1-Phosphate in Photoreceptors and Its Relevance to Retinal Degeneration
por: Terao, Ryo, et al.
Publicado: (2019)

Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression
por: Takahashi, Chiharu, et al.
Publicado: (2017)

Use of gas chromatography mass spectrometry to elucidate metabolites predicting the phenotypes of IgA nephropathy in hyper IgA mice
por: Kurano, Makoto, et al.
Publicado: (2019)

Genomic Determinants of Triglyceride and Cholesterol Distribution into Lipoprotein Fractions in the Rat
por: Hodúlová, Miloslava, et al.
Publicado: (2014)

Vascular protection by high-density lipoprotein-associated sphingosine-1-phosphate
por: Wang, Xi, et al.
Publicado: (2017)

Implication of Ceramide, Ceramide 1-Phosphate and Sphingosine 1-Phosphate in Tumorigenesis
por: Gangoiti, Patricia, et al.
Publicado: (2008)

Sphingosine kinase-2 prevents macrophage cholesterol accumulation and atherosclerosis by stimulating autophagic lipid degradation
por: Ishimaru, Kazuhiro, et al.
Publicado: (2019)

The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus
por: Tong, Xunliang, et al.
Publicado: (2014)

Postprandial Lipoproteins and Cardiovascular Disease Risk in Diabetes Mellitus
por: Enkhmaa, Byambaa, et al.
Publicado: (2010)

Ceramide and Sphingosine 1-Phosphate in Liver Diseases
por: Park, Woo-Jae, et al.
Publicado: (2020)

Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels
por: Grammatikos, Georgios, et al.
Publicado: (2016)

Characterization of the LPS and 3OHFA Contents in the Lipoprotein Fractions and Lipoprotein Particles of Healthy Men
por: Rehues, Pere, et al.
Publicado: (2021)

The Ratio of Oxidized Lipoprotein(a) to Native Lipoprotein(a) and the Endothelial Function in Patients with Type 2 Diabetes Mellitus
por: Kotani, Kazuhiko, et al.
Publicado: (2019)

Altered Distribution of Unesterified Cholesterol among Lipoprotein Subfractions of Patients with Diabetes Mellitus Type 2
por: Kolb, Livia Noemi, et al.
Publicado: (2023)

High -density lipoprotein cholesterol as a predictor for diabetes mellitus
por: Wu, Hong, et al.
Publicado: (2018)

Energy balance and the sphingosine-1-phosphate/ceramide axis
por: Green, Cara, et al.
Publicado: (2017)

Analysis of lipoprotein transport depletion in Vibrio cholerae using CRISPRi
por: Caro, Florence, et al.
Publicado: (2019)

Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human
por: Sato, Masaya, et al.
Publicado: (2016)

Heterogeneity of lipoprotein particles in hepatic Golgi fractions
Publicado: (1982)

Carbamylated lipoproteins in diabetes
por: Denimal, Damien
Publicado: (2023)

Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence
por: Uranbileg, Baasanjav, et al.
Publicado: (2016)

Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein
por: Sato, Megumi, et al.
Publicado: (2016)

Lipoprotein particle distribution and skeletal muscle lipoprotein lipase activity after acute exercise
por: Harrison, Michael, et al.
Publicado: (2012)

Correlation of Triglyceride-Rich Lipoprotein Cholesterol and Diabetes Mellitus in Stroke Patients
por: Luo, Ruiqing, et al.
Publicado: (2022)

Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate
por: Piccoli, Marco, et al.
Publicado: (2023)

Small Dense Low-Density Lipoprotein Level in Newly Diagnosed Type 2 Diabetes Mellitus Patients With Normal Low-Density Lipoprotein
por: Juhi, Ayesha, et al.
Publicado: (2023)

Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins
por: Hammad, Samar M., et al.
Publicado: (2020)

A Computational Model for the Analysis of Lipoprotein Distributions in the Mouse: Translating FPLC Profiles to Lipoprotein Metabolism
por: Sips, Fianne L. P., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jl4t8dc1cjshueussj1olshlmn